Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1653) 1653
amoxicillin-potassium clavulanate combination - therapeutic use (1170) 1170
science & technology (1087) 1087
life sciences & biomedicine (1083) 1083
female (1004) 1004
male (1002) 1002
anti-bacterial agents - therapeutic use (934) 934
adult (583) 583
middle aged (540) 540
drug therapy, combination - therapeutic use (527) 527
biological and medical sciences (522) 522
medical sciences (514) 514
amoxicillin - therapeutic use (482) 482
amoxicillin-potassium clavulanate combination (445) 445
aged (415) 415
clavulanic acids - therapeutic use (386) 386
infectious diseases (379) 379
child (345) 345
treatment outcome (344) 344
pharmacology. drug treatments (326) 326
adolescent (300) 300
child, preschool (287) 287
antibiotics. antiinfectious agents. antiparasitic agents (280) 280
microbiology (267) 267
acute disease (249) 249
antibacterial agents (248) 248
amoxicillin-potassium clavulanate combination - administration & dosage (236) 236
pharmacology & pharmacy (232) 232
infant (227) 227
antibiotics (216) 216
anti-bacterial agents - administration & dosage (211) 211
microbial sensitivity tests (196) 196
prospective studies (186) 186
amoxicillin-potassium clavulanate combination - adverse effects (182) 182
amoxicillin (167) 167
abridged index medicus (164) 164
aged, 80 and over (149) 149
general & internal medicine (149) 149
animals (146) 146
bacterial infections - drug therapy (145) 145
double-blind method (145) 145
administration, oral (143) 143
amoxicillin-potassium clavulanate combination - pharmacology (141) 141
medicine, general & internal (140) 140
anti-bacterial agents - pharmacology (133) 133
drug therapy, combination (133) 133
anti-bacterial agents - adverse effects (131) 131
dentistry (129) 129
drug therapy, combination - administration & dosage (128) 128
pediatrics (128) 128
cephalosporins - therapeutic use (125) 125
otitis media - drug therapy (125) 125
amoxicillin - administration & dosage (117) 117
drug therapy, combination - adverse effects (114) 114
surgery (109) 109
risk factors (104) 104
drug combinations - therapeutic use (103) 103
bacterial diseases (102) 102
follow-up studies (102) 102
clavulanic acids - administration & dosage (101) 101
time factors (101) 101
amoxicillin - adverse effects (98) 98
drug administration schedule (96) 96
human bacterial diseases (96) 96
retrospective studies (96) 96
respiratory tract infections - drug therapy (94) 94
metronidazole - therapeutic use (93) 93
urinary tract infections - drug therapy (93) 93
anti-infective agents - therapeutic use (89) 89
health aspects (89) 89
immunology (85) 85
dentistry, oral surgery & medicine (84) 84
clavulanic acids - adverse effects (82) 82
drug resistance, bacterial (81) 81
drug therapy (81) 81
young adult (81) 81
antibiotic prophylaxis (75) 75
recurrence (75) 75
sinusitis - drug therapy (75) 75
streptococcus pneumoniae - drug effects (75) 75
tomography, x-ray computed (74) 74
ciprofloxacin - therapeutic use (73) 73
community-acquired infections - drug therapy (72) 72
diagnosis, differential (71) 71
surgical wound infection - prevention & control (71) 71
clavulanic acid (70) 70
infections (69) 69
pneumonia, bacterial - drug therapy (64) 64
cefuroxime - therapeutic use (63) 63
analysis (62) 62
chronic disease (59) 59
care and treatment (58) 58
bronchitis - drug therapy (56) 56
escherichia coli infections - drug therapy (56) 56
otorhinolaryngology (56) 56
azithromycin - therapeutic use (55) 55
combined modality therapy (55) 55
penicillins - therapeutic use (55) 55
medicine & public health (54) 54
randomized controlled trials as topic (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1520) 1520
French (110) 110
Spanish (68) 68
Russian (44) 44
German (34) 34
Japanese (19) 19
Dutch (11) 11
Italian (9) 9
Hungarian (5) 5
Polish (5) 5
Czech (4) 4
Portuguese (4) 4
Turkish (4) 4
Bulgarian (3) 3
Romanian (2) 2
Croatian (1) 1
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Amoxicillin–clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial
by Goyal, Vikas and Grimwood, Keith and Byrnes, Catherine A and Morris, Peter S and Masters, I Brent and Ware, Robert S and McCallum, Gabrielle B and Binks, Michael J and Marchant, Julie M and van Asperen, Peter and O'Grady, Kerry-Ann F and Champion, Anita and Buntain, Helen M and Petsky, Helen and Torzillo, Paul J and Chang, Anne B
The Lancet (British edition), ISSN 0140-6736, 10/2018, Volume 392, Issue 10154, pp. 1197 - 1206
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Bronchiectasis - drug therapy | Double-Blind Method | Administration, Oral | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Disease Progression | Young Adult | Anti-Bacterial Agents - therapeutic use | Azithromycin - adverse effects | beta-Lactamase Inhibitors - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Azithromycin - therapeutic use | Time Factors | beta-Lactamase Inhibitors - therapeutic use | Adolescent | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Equivalence Trials as Topic | Child | Clinical trials | Bronchiectasis | Clavulanate | Azithromycin | Amoxicillin | Medical research | Microbiology | Hypersensitivity | Cystic fibrosis | Risk | Drug resistance | Evidence-based medicine | Blood | Quality of life | Streptococcus infections | Studies | Randomization | Antibiotics | Fibrosis | Penicillin | Children | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Treating Foot Infections in Diabetic Patients: A Randomized, Multicenter, Open-Label Trial of Linezolid versus Ampicillin-Sulbactam/Amoxicillin-Clavulanate
by Benjamin A. Lipsky and Kamal Itani and Carl Norden and The Linezolid Diabetic Foot Infections Study Group and Linezolid Diabetic Foot Infections Study Group and the Linezolid Diabetic Foot Infections Study Group
Clinical infectious diseases, ISSN 1058-4838, 1/2004, Volume 38, Issue 1, pp. 17 - 24
Osteomyelitis | Pathogens | Antibiotics | Diabetes complications | Major Articles | Diabetes mellitus | Diabetic foot | Bones | Infections | Diabetes | Medical cures | Linezolid | Ampicillin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Diabetes Complications | Acetamides - therapeutic use | Humans | Sulbactam - therapeutic use | Foot Diseases - complications | Treatment Outcome | Drug Therapy, Combination | Foot Diseases - drug therapy | Oxazolidinones - therapeutic use | Methicillin | Diabetics | Statistics | Foot diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough
by Marchant, Julie and Masters, Ian Brent and Champion, Anita and Petsky, Helen and Chang, Anne B
Thorax, ISSN 0040-6376, 08/2012, Volume 67, Issue 8, pp. 689 - 693
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Cough - drug therapy | Humans | Child, Preschool | Infant | Male | Treatment Outcome | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Bronchitis - drug therapy | Adolescent | Bronchitis - complications | Female | Bronchoalveolar Lavage Fluid - cytology | Cough - microbiology | Child | Chronic Disease | Antibiotics | Usage | Amoxicillin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Once-Daily, High-Dose Levofloxacin versus Ticarcillin-Clavulanate Alone or Followed by Amoxicillin-Clavulanate for Complicated Skin and Skin-Structure Infections: A Randomized, Open-Label Trial
by Donald R. Graham and David A. Talan and Ronald L. Nichols and Christopher Lucasti and Michael Corrado and Nancy Morgan and Cynthia L. Fowler
Clinical infectious diseases, ISSN 1058-4838, 8/2002, Volume 35, Issue 4, pp. 381 - 389
Osteomyelitis | Pathogens | Diabetes complications | Major Articles | Antimicrobials | Ulcers | Aerobic bacteria | Infections | Skin | Diabetes | Dosage | Infectious diseases | Bacterial diseases | Human bacterial diseases | Tuberculosis and atypical mycobacterial infections | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Levofloxacin | Humans | Middle Aged | Ofloxacin - therapeutic use | Ticarcillin - adverse effects | Male | Drug Therapy, Combination - adverse effects | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Clavulanic Acids - adverse effects | Ofloxacin - adverse effects | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Ofloxacin - administration & dosage | Female | Anti-Infective Agents - adverse effects | Ticarcillin - administration & dosage | Clavulanic Acids - administration & dosage | Anti-Infective Agents - therapeutic use | Clavulanic Acids - therapeutic use | Skin Diseases - drug therapy | Treatment Outcome | Drug Therapy, Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Anti-Infective Agents - administration & dosage | Drug Therapy, Combination - administration & dosage | Ticarcillin - therapeutic use | Infection | Evaluation | Amoxicillin | Ticarcillin | Clavulanate | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Amoxicillin-Clavulanate vs Ciprofloxacin for the Treatment of Uncomplicated Cystitis in Women: A Randomized Trial
by Hooton, Thomas M and Scholes, Delia and Gupta, Kalpana and Stapleton, Ann E and Roberts, Pacita L and Stamm, Walter E
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2005, Volume 293, Issue 8, pp. 949 - 955
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | General aspects | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Single-Blind Method | Ciprofloxacin - therapeutic use | Humans | Cystitis - microbiology | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Cystitis - drug therapy | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Ciprofloxacin - administration & dosage | Adult | Female | Vagina - microbiology | Escherichia coli - growth & development | Anti-Bacterial Agents - administration & dosage | Comparative studies | Infections | Antibiotics | Drug therapy | Effectiveness studies | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Reduced-concentration clavulanate for young children with acute otitis media
by Hoberman, Alejandro and Paradise, Jack L and Rockette, Howard E and Jeong, Jong-Hyeon and Kearney, Diana H and Bhatnagar, Sonika and Shope, Timothy R and Muñiz, Gysella and Martin, Judith M and Kurs-Lasky, Marcia and Haralam, MaryAnn and Pope, Marcia A and Nagg, Jennifer P and Zhao, Wenchen and Miah, Mohammad Kowser and Beumer, Jan and Venkataramanan, Raman and Shaikh, Nader
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 07/2017, Volume 61, Issue 7
Acute otitis media | Antimicrobial treatment | Amoxicillin-clavulanate | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Clavulanic Acid - administration & dosage | Humans | Infant | Male | Otitis Media - drug therapy | Diarrhea - chemically induced | Clavulanic Acid - adverse effects | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Clavulanic Acid - therapeutic use | Anti-Bacterial Agents - therapeutic use | Dermatitis - etiology | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Anti-Bacterial Agents - administration & dosage | Infant, Newborn | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Anaphylaxis to amoxicillin-clavulanate: Differentiating the components
by Dudgeon, Matthew and Carrillo-Martin, Ismael and Gonzalez-Estrada, Alexei
Annals of allergy, asthma, & immunology, ISSN 1081-1206, 04/2019, Volume 122, Issue 4, pp. 427 - 428
Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Drug Hypersensitivity - etiology | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Immunoglobulin E - immunology | Anaphylaxis - chemically induced | Drug Hypersensitivity - immunology | Humans | Middle Aged | Anaphylaxis - immunology | Male
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections
by Malangoni, Mark A and Song, James and Herrington, Janet and Choudhri, Shurjeel and Pertel, Peter
Annals of surgery, ISSN 0003-4932, 08/2006, Volume 244, Issue 2, pp. 204 - 211
Biological and medical sciences | General aspects | Medical sciences | Antibacterial agents | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Fluoroquinolones | Intestinal Perforation - complications | Appendicitis - complications | Injections, Intravenous | Prospective Studies | Aza Compounds - therapeutic use | Humans | Middle Aged | Abdominal Abscess - drug therapy | Stomach Rupture - complications | Male | Quinolines - administration & dosage | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Safety | Penicillanic Acid - analogs & derivatives | Aza Compounds - administration & dosage | Double-Blind Method | Administration, Oral | Bacterial Infections - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Treatment Outcome | Cross Infection - drug therapy | Abdominal Abscess - microbiology | Quinolines - therapeutic use | Gram-Positive Bacterial Infections - drug therapy | Anti-Bacterial Agents - administration & dosage | Piperacillin - therapeutic use | Index Medicus | Abridged Index Medicus | Randomized, Controlled Trials
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate
by Lipsky, Benjamin A and Giordano, Philip and Choudhri, Shurjeel and Song, James
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 8/2007, Volume 60, Issue 2, pp. 370 - 376
Fluoroquinolones | β-lactam inhibitors | Penicillins | Complicated skin and skin structure infections | Diabetes. Impaired glucose tolerance | Pharmacology. Drug treatments | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Associated diseases and complications | Antibiotics. Antiinfectious agents. Antiparasitic agents | Aza Compounds - therapeutic use | Humans | Aza Compounds - adverse effects | Male | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - adverse effects | Penicillanic Acid - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Penicillanic Acid - adverse effects | Bacterial Infections - microbiology | Penicillanic Acid - analogs & derivatives | Databases, Factual | Double-Blind Method | Bacterial Infections - drug therapy | Diabetic Foot - drug therapy | Diabetic Foot - surgery | Bacterial Infections - surgery | Diabetic Foot - microbiology | Piperacillin - adverse effects | Aged | Quinolines - therapeutic use | Quinolines - adverse effects | Piperacillin - therapeutic use | Skin diseases | Chemotherapy | Infections | Diabetes | Microbiology | Feet | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam
by Birgy, André and Delecourt, Marine and Geslain, Guillaume and Desselas, Emilie and Caseris, Marion and Magnan, Mélanie and Mariani-Kurkdjian, Patricia and Bidet, Philippe and Bonacorsi, Stéphane
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 07/2017, Volume 72, Issue 7, pp. 1911 - 1914
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Escherichia coli - drug effects | Humans | Amdinocillin - administration & dosage | beta-Lactamases - biosynthesis | Penicillinase - genetics | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Amdinocillin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | beta-Lactamases - genetics | Amdinocillin - pharmacology | Urinary Tract Infections - microbiology | Drug Therapy, Combination | France | Escherichia coli Infections - drug therapy | Genome, Bacterial | Escherichia coli - enzymology | Escherichia coli Infections - microbiology | Sequence Analysis, DNA | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Urinary Tract Infections - drug therapy | Escherichia coli - genetics | Polymorphism, Single Nucleotide | Anti-Bacterial Agents - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Are third-generation cephalosporins associated with a better prognosis than amoxicillin–clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?
by Batard, E and Javaudin, F and Kervagoret, E and Caruana, E and Le Bastard, Q and Chapelet, G and Goffinet, N and Montassier, E
Clinical microbiology and infection, ISSN 1198-743X, 11/2018, Volume 24, Issue 11, pp. 1171 - 1176
Amoxicillin–clavulanate | Community-onset pneumonia | Ceftriaxone | Cefotaxime | Mortality | Cephalosporins - therapeutic use | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Community-Acquired Infections - drug therapy | Humans | Aged, 80 and over | Female | Male | Pneumonia, Bacterial - drug therapy | Aged | Retrospective Studies | Cephalosporins - classification | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Treatment of actinomycetoma due to Nocardia spp. with amoxicillin–clavulanate
by Bonifaz, A and Flores, P and Saúl, A and Carrasco‐Gerard, E and Ponce, R.M
British journal of dermatology (1951), ISSN 0007-0963, 02/2007, Volume 156, Issue 2, pp. 308 - 311
mycetoma | Nocardia sp | co‐amoxiclav | actinomycetoma | Nocardia brasiliensis | Mycetoma | Actinomycetoma | Co-amoxiclav | Life Sciences & Biomedicine | Dermatology | Science & Technology | Skin Diseases, Bacterial - microbiology | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Skin Diseases, Bacterial - drug therapy | Dapsone - therapeutic use | Anti-Bacterial Agents - therapeutic use | Amikacin - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Adult | Mexico | Aged | Retrospective Studies | Drug Therapy, Combination | Nocardia Infections - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text In Vitro and In Vivo Efficacy of β-Lactams against Replicating and Slowly Growing/Nonreplicating Mycobacterium tuberculosis
by Suresh Solapure and Neela Dinesh and Radha Shandil and Vasanthi Ramachandran and Sreevalli Sharma and Deepa Bhattacharjee and Samit Ganguly and Jitendar Reddy and Vijaykamal Ahuja and Vijender Panduga and Manish Parab and K. G. Vishwas and Naveen Kumar and Meenakshi Balganesh and V. Balasubramanian
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2013, Volume 57, Issue 6, pp. 2506 - 2510
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antibiotics. Antiinfectious agents. Antiparasitic agents | Tuberculosis, Pulmonary - microbiology | beta-Lactams - pharmacokinetics | Clavulanic Acid - administration & dosage | Humans | Thienamycins - pharmacokinetics | Tuberculosis, Pulmonary - drug therapy | Mycobacterium tuberculosis - drug effects | Amoxicillin-Potassium Clavulanate Combination - pharmacology | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Microbial Sensitivity Tests - standards | Female | Drug Therapy, Combination | Disease Models, Animal | Thienamycins - therapeutic use | Thienamycins - administration & dosage | Clavulanic Acid - pharmacology | Streptomycin - pharmacology | Treatment Outcome | Clavulanic Acid - pharmacokinetics | Thienamycins - pharmacology | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Clavulanic Acid - therapeutic use | beta-Lactams - pharmacology | Animals | Amoxicillin-Potassium Clavulanate Combination - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Anti-Bacterial Agents - pharmacology | Mice | Mice, Inbred BALB C | beta-Lactams - therapeutic use | Anti-Bacterial Agents - administration & dosage | beta-Lactams - administration & dosage | Mycobacterium tuberculosis - growth & development | Index Medicus | Experimental Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Fosfomycin in a single dose versus a 7-day course of amoxicillin- clavulanate for the treatment of asymptomatic bacteriuria during pregnancy
by Estebanez, A and Pascual, R and Gil, V and Ortiz, F and Santibáñez, M and Pérez Barba, C
European journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 12/2009, Volume 28, Issue 12, pp. 1457 - 1464
Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Bacterial diseases of the urinary system | Antibacterial agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Recurrence | Fosfomycin - therapeutic use | Prospective Studies | Humans | Treatment Outcome | Amoxicillin-Potassium Clavulanate Combination - administration & dosage | Pregnancy | Young Adult | Anti-Bacterial Agents - therapeutic use | Amoxicillin-Potassium Clavulanate Combination - therapeutic use | Fosfomycin - administration & dosage | Pregnancy Complications, Infectious - drug therapy | Adult | Female | Anti-Bacterial Agents - administration & dosage | Longitudinal Studies | Bacteriuria - drug therapy | Care and treatment | Pregnant women | Research vessels | Dosage and administration | Universities and colleges | Clavulanate | Fosfomycin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights